Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Hedrick MN"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kholmanskikh O; Belgium FAMHP, Brussels, Belgium., Wang YM; US FDA, Silver Spring, MD, USA., Hersey S; Bristol Myers Squibb, Lawrenceville, NJ, USA., Wadhwa M; UK MHRA, London, UK., Block K; Genentech, South San Francisco, CA, USA., Bandukwala A; US FDA, Silver Spring, MD, USA., Szapacs M; Abbvie, Philadelphia, PA, USA., Weiner R; Takeda, Cambridge, MA, USA., Awwad K; Abbvie, Ludwigshafen, Germany., Dessy F; GlaxoSmithKline, Rixensart, Belgium.; Takeda, Cambridge, MA, USA., Downing S; Takeda, Cambridge, MA, USA., Du X; US FDA, Silver Spring, MD, USA., Garofolo F; BRI Frontage, Vancouver, BC, Canada., Harris S; HilleVax, Cambridge, MA, USA., Hou V; Moderna, Cambridge, MA, USA., Jones J; Bristol Myers Squibb, Lawrenceville, NJ, USA., Kar S; WRIB, Toronto, ON, Canada., Kinhikar A; Novartis, Cambridge, MA, USA., Li M; Stoke, Cambridge, MA, USA., Mathews J; Ionis, Carlsbad, CA, USA., Meissen J; AstraZeneca, South San Francisco, CA, USA., Sumner GO; Regeneron, Tarrytown, NY, USA., Pan L; Takeda, Cambridge, MA, USA., Sanderink G; Sanofi Pasteur, Swiftwater, PA, USA., Scully I; Pfizer, Pearl River, NY, USA., Stanta J; Celerion, Stevenage, UK., Tanaka Y; Japan MHLW, Tokyo, Japan., Vauleon S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Wagner L; US FDA, Silver Spring, MD, USA., Wang K; GlaxoSmithKline, Collegeville, PA, USA., Zhu L; Moderna, Cambridge, MA, USA., Eck S; AstraZeneca, Gaithersburg, MD, USA., Lin YD; Takeda, Cambridge, MA, USA., Azadeh M; Ultragenyx, Cambridge, MA, USA., Decman V; GlaxoSmithKline, Collegeville, PA, USA., Diebold S; UK MHRA, London, UK., Du X; US FDA, Silver Spring, MD, USA., Goihberg P; Pfizer, Andover, MA, USA., Alcaide EG; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gonneau C; Labcorp, Meyrin, Switzerland., Hedrick MN; Bristol Myers Squibb, Lawrenceville, NJ, USA., Hopkins G; 2seventy Bio, Cambridge, MA, USA., Kar S; WRIB, Toronto, ON, Canada., Loschko J; Pfizer, Pearl River, NY, USA., McCausland M; Q2 Solutions, Atlanta. GA, USA., Mendez L; Merck, Kenilworth, NJ, USA., Sehra S; Incyte, Wilmington, DE, USA., Stevens E; Pfizer, Groton, CT, USA., Sun YS; Bristol Myers Squibb, Lawrenceville, NJ, USA., Tangri S; Navigate, a Novartis Subsidiary, San Diego, CA, USA., Trampont PC; Moderna, Cambridge, MA, USA., Cludts I; UK MHRA, London, UK., Dysinger M; Alexion, New Haven, CT, USA., Kavita U; Spark Therapeutics, Plainsboro, NJ, USA., Sugimoto H; Takeda, Cambridge, MA, USA., Chilewski S; Bristol Myers Squibb, Lawrenceville, NJ, USA., Grimaldi C; Regeneron, Tarrytown, NY, USA., Jiang Y; GlaxoSmithKline, Collegeville, PA, USA., Kamerud J; Pfizer, Andover, MA, USA., Liu S; Pfizer, Kirkland, QC, Canada., Owen C; Pfizer, Groton, CT, USA., Palackal N; Regeneron, Tarrytown, NY, USA., Petit-Frere C; Fresenius Kabi, Bad Homburg, Germany., Pine S; Sanofi, Ghent, Belgium., Abhari MR; US FDA, Silver Spring, MD, USA., Scheibner K; US FDA, Silver Spring, MD, USA., Williams L; Bristol Myers Squibb, Lawrenceville, NJ, USA., Xu T; Frontage, Exton, PA, USA., Zhang G; Alnylam, Cambridge, MA, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2024; Vol. 16 (8), pp. 179-220. Date of Electronic Publication: 2024 May 22.
Autor:
Sumner G; Regeneron, Tarrytown, NY, USA., Keller S; AbbVie, South San Francisco, CA, USA., Huleatt J; Sanofi Pasteur, Swiftwater, PA, USA., Staack RF; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Wagner L; US FDA, Silver Spring, MD, USA., Azadeh M; Alkermes, Waltham, MA, USA., Bandukwala A; US FDA, Silver Spring, MD, USA., Cao L; Sangamo, Brisbane, CA, USA., Du X; US FDA, Silver Spring, MD, USA., Salinas GF; Janssen, Leiden, South Holland, Netherlands., Garofolo F; BRI Frontage, Vancouver, BC, Canada., Harris S; HilleVax, Cambridge, MA, USA., Hopper S; UK MHRA, London, UK., Irwin C; Health Canada, Ottawa, ON, Canada., Ji Q; AbbVie, North Chicago, IL, USA., Joseph J; Health Canada, Ottawa, ON, Canada., King L; Pfizer, Cambridge, MA, USA., Kinhikar A; Novartis, Cambridge, MA, USA., Lu Y; US FDA, Silver Spring, MD, USA., Luo R; Crinetics, San Diego, CA, USA., Mabrouk O; Biogen, Cambridge, MA, USA., Malvaux L; GSK Vaccines, Rixensart, Belgium., Marshall JC; Moderna, Cambridge, MA, USA., McGuire K; Regeneron, Tarrytown, NY, USA., Mikol V; Sanofi, Vitry-sur-Seine, France., Neely R; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Qiu X; WRIB, Montreal, QC, Canada., Saito Y; Japan MHLW, Tokyo, Japan., Salaun B; GSK Vaccines, Rixensart, Belgium., Scully I; Pfizer, Pearl River, NY, USA., Smeraglia J; UCB, Braine-l'Alleud, Wallonia, Belgium., Solstad T; Norway NoMA, Oslo, Norway., Stoop J; Janssen, Leiden, South Holland, Netherlands., Tang H; GlaxoSmithKline, Collegeville, PA, USA., Teixeira P; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Wang Y; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Wright M; GlaxoSmithKline, Stevenage, UK., Mendez L; Merck, Kenilworth, NJ, USA., Beaver C; Syneos Health, Toronto, ON, Canada., Eacret J; Merck, West Point, PA, USA., Au-Yeung A; Genentech, South San Francisco, CA, USA., Decman V; GlaxoSmithKline, Philadelphia, PA, USA., Dessy F; GSK Vaccines, Rixensart, Belgium., Eck S; AstraZeneca, Gaithersburg, MD, USA., Goihberg P; Pfizer, Andover, MA, USA., Alcaide EG; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Gonneau C; Labcorp, Meyrin, Switzerland., Grugan K; Janssen R&D, Spring House, Pa, USA., Hedrick MN; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Kar S; WRIB, Montreal, QC, Canada., Sehra S; Incyte, Wilmington, DE, USA., Stevens E; Pfizer, Groton, CT, USA., Stevens C; Pfizer, Andover, MA, USA., Sun Y; Bristol-Myers Squibb, Lawrenceville, NJ, USA., McCush F; Pfizer, Groton, CT, USA., Williams L; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Fischer S; Genentech, South San Francisco, CA, USA., Wu B; Janssen R&D, Spring House, Pa, USA., Jordan G; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Burns C; UK MHRA, London, UK., Cludts I; UK MHRA, London, UK., Coble K; Boehringer Ingelheim, Ridgefield, CT, USA., Grimaldi C; Regeneron, Tarrytown, NY, USA., Henderson N; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Joyce A; Pfizer, Groveland, MA, USA., Lotz G; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Lu Y; Sangamo, Brisbane, CA, USA., Luo L; Merck, West Point, PA, USA., Neff F; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Sperinde G; Genentech, South San Francisco, CA, USA., Stubenrauch KG; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Wang Y; WRIB, Montreal, QC, Canada., Ware M; Janssen R&D, Spring House, Pa, USA., Xu W; Merck, West Point, PA, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2023 Aug; Vol. 15 (15), pp. 861-903. Date of Electronic Publication: 2023 Aug 16.
Autor:
Hersey S; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Keller S; AbbVie, South San Francisco, CA, USA., Mathews J; Ionis, Carlsbad, CA, USA., King L; Pfizer, Cambridge, MA, USA., Bandukwala A; US FDA, Silver Spring, MD, USA., Berisha F; Janssen R&D, Spring House, PA, USA., Birchler M; GlaxoSmithKline, Collegeville, PA, USA., Bower J; Precision for Medicine, Bethesda, MD, USA., Clausen V; Alnylam, Cambridge, MA, USA., Duarte J; F. Hoffmann-La Roche, Basel, Switzerland., Garofolo F; BRI - a Frontage Company, Vancouver, BC, Canada., Hopper S; UK MHRA, London, UK., Kar S; WRIB, Montreal, QC, Canada., Mabrouk O; Biogen, Cambridge, MA, USA., Marshall JC; Moderna, Cambridge, MA, USA., McGuire K; Regeneron, Tarrytown, NY, USA., Naughton M; GlaxoSmithKline, Stevenage, UK., Saito Y; Japan MHLW-NIHS, Tokyo, Japan., Schuhmann I; Novartis, Basel, Switzerland., Sperinde G; Genentech, South San Francisco, CA, USA., Teixeira P; F. Hoffmann-La Roche, Basel, Switzerland., Vitaliti A; Novartis, Basel, Switzerland., Wang YM; US FDA, Silver Spring, MD, USA., Wnek R; Merck, Kenilworth, NJ, USA., Zhang Y; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Spitz S; Incyte Research Institute, Wilmington, DE, USA., Decman V; GlaxoSmithKline, Philadelphia, PA, USA., Eck S; AstraZeneca, Gaithersburg, MD, USA., Estevam J; Takeda, Cambridge, MA, USA., Goihberg P; Pfizer, Andover, MA, USA., Alcaide EG; F. Hoffmann-La Roche, Basel, Switzerland., Gonneau C; Labcorp, Meyrin, Switzerland., Hedrick MN; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Hopkins G; Bluebird Bio, Cambridge, MA, USA., Junker F; F. Hoffmann-La Roche, Basel, Switzerland., Nuti S; GSK vaccines, Rockville, MD, USA., Sommer U; Novartis, Basel, Switzerland., Standifer N; AstraZeneca, South San Francisco, CA, USA., Stevens C; Pfizer, Cambridge, MA, USA., Stevens E; Pfizer, Groton, CT, USA., Hendricks C; Sanofi, Framingham, MA, USA., Wadhwa M; UK MHRA, London, UK., Torri A; Regeneron, Tarrytown, NY, USA., Ma M; Alexion, New Haven, CT, USA., Harris S; HilleVax, Cambridge, MA, USA., Kumar S; EMD Serono, Andover, MA, USA., Partridge MA; Regeneron, Tarrytown, NY, USA., Caiazzo T; Pfizer, Cambridge, MA, USA., Chilewski S; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Cludts I; UK MHRA, London, UK., Coble K; Boehringer Ingelheim, Ridgefield, CT, USA., Gorovits B; Sana Bio, Cambridge, MA, USA., Grimaldi C; Boehringer Ingelheim, Ridgefield, CT, USA., Jordan G; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Kamerud J; Pfizer, Cambridge, MA, USA., Leary B; Pfizer, Cambridge, MA, USA., Liang M; AstraZeneca, South San Francisco, CA, USA., Lim H; Genentech, South San Francisco, CA, USA., Mayer A; GlaxoSmithKline, Collegeville, PA, USA., O'Connor E; AstraZeneca, Gaithersburg, MD, USA., Palackal N; Regeneron, Tarrytown, NY, USA., Poetzl J; Sandoz, Munich, Germany., Prior S; UK MHRA, London, UK., Abhari MR; US FDA, Silver Spring, MD, USA., Savoie N; WRIB, Montreal, QC, Canada., Soo C; Health Canada, Ottawa, ON, Canada., Ware M; Janssen R&D, Spring House, PA, USA., Wu B; Janssen R&D, Spring House, PA, USA., Xu Y; Merck, West Point, PA, USA., Yang TY; Janssen R&D, Spring House, PA, USA., Zoghbi J; Sanofi, Framingham, MA, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2022 May; Vol. 14 (10), pp. 627-692. Date of Electronic Publication: 2022 May 17.
Autor:
Sarikonda G; Navigate BioPharma Services, Inc., a Novartis subsidiary, Carlsbad, California, USA., Mathieu M; Caprion Biosciences Inc, Montréal, Québec, Canada., Natalia M; Takeda Pharmaceutical International, Cambridge, Massachusetts, USA., Pahuja A; Navigate BioPharma Services, Inc., a Novartis subsidiary, Carlsbad, California, USA., Xue Q; Takeda Pharmaceutical International, Cambridge, Massachusetts, USA., Pierog PL; Takeda Pharmaceutical International, Cambridge, Massachusetts, USA., Trampont PC; Nexelis, Seattle, Washington, USA., Decman V; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Reynolds S; Curiox Biosystems, Boston, Massachusetts, USA., Hanafi LA; Caprion Biosciences Inc, Montréal, Québec, Canada., Sun YS; Bristol Myers Squibb, Lawrenceville, New Jersey, USA., Eck S; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, Maryland, USA., Hedrick MN; Bristol Myers Squibb, Lawrenceville, New Jersey, USA., Stewart JJ; Flow Contract Site Laboratory, Bothell, Washington, USA., Tangri S; Navigate BioPharma Services, Inc., a Novartis subsidiary, Carlsbad, California, USA., Litwin V; Caprion Biosciences Inc, Montréal, Québec, Canada., Dakappagari N; Navigate BioPharma Services, Inc., a Novartis subsidiary, Carlsbad, California, USA.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2021 Jan; Vol. 100 (1), pp. 79-91. Date of Electronic Publication: 2020 Dec 29.
Autor:
Quadrini KJ; Department of Research and Development, ICON Laboratory Services, Farmingdale, New York, USA., Patti-Diaz L; Clinical Flow Cytometry, Department of Translational Pathology and Biomarker Technologies, Bristol-Myers Squibb, Lawrenceville, New Jersey, USA., Maghsoudlou J; Department of Research and Development, ICON Laboratory Services, Farmingdale, New York, USA., Cuomo J; Cellular Immunology, ICON Laboratory Services, Farmingdale, New York, USA., Hedrick MN; Clinical Flow Cytometry, Department of Translational Pathology and Biomarker Technologies, Bristol-Myers Squibb, Lawrenceville, New Jersey, USA., McCloskey TW; Department of Research and Development, ICON Laboratory Services, Farmingdale, New York, USA.
Publikováno v:
Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2021 Jan; Vol. 100 (1), pp. 103-114. Date of Electronic Publication: 2021 Jan 12.
Autor:
Czechowska K; Altmattstrasse 1B, 6418, Rothenthurm, SZ, Switzerland., Lannigan J; Flow Cytometry Support Services, LLC, Alexandria, Virginia.; Flow Cytometry Core, University of Virginia, School of Medicine, Charlottesville, Virginia., Aghaeepour N; Department of Anesthesiology, Department of Biomedical Data Sciences, Department of Pediatrics, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford University, Stanford, California., Back JB; Department of Oncology, Wayne State University, Detroit, Michigan., Begum J; Flow Cytometry Facility, Barts Cancer Institute, Queen Mary University of London, London, UK., Behbehani G; Wexner Medical Center, Ohio State University, Columbus, Ohio., Bispo C; Parnassus Flow Cytometry Core, University of California San Francisco, San Francisco, California.; ISAC SRL Emerging Leader, Arlington, Virginia., Bitoun D; EMA Regional Marketing, BD Lifesciences, International Office, Belgium., Fernández AB; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin, Ireland., Boova ST; High Burden HIV Global Markets, Beckman Coulter, Inc., Miami, Florida., Brinkman RR; Medical Genetics, University of British Columbia and British Columbia Cancer, Vancouver, British Columbia, Canada.; Cytapex Bioinformatics Inc., Vancouver, British Columbia, Canada., Ciccolella CO; Omiq, Inc., Co-Founder and CEO, Santa Clara, California., Cotleur B; Biogen, Acute Neurology, Cambridge, Massachusetts., Davies D; Science Technology Platform Training Lead, Francis Crick Institute, London, UK., Dela Cruz GV; Novo Nordisk Foundation Center for Stem Cell Biology - DanStem, Flow Cytometry Platform, Copenhagen, Denmark., Del Rio-Guerra R; Flow Cytometry and Cell Sorting Facility, Larner College of Medicine, University of Vermont, Burlington, Vermont., Des Lauriers-Cox AM; Flow Cytometry Core Facility Assistant Manager, University of Michigan, Ann Arbor, Michigan., Douagi I; Flow Cytometry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Dumrese C; Cytometry Facility, University of Zürich, Zürich, Switzerland., Bonilla Escobar DL; Immunology Department, MD Anderson Cancer Center, University of Texas, Houston, Texas., Estevam J; Center of Biomarker Innovation and Development, Takeda Pharmaceuticals, Cambridge, Massachusetts., Ewald C; Cytometry Facility Senior Scientist, University of Zürich, Zürich, Switzerland., Fossum A; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Gaudillière B; Anesthesiology Department, Stanford University, Stanford, California., Green C; Flow Cytometry Biomarkers Development Sciences, Genentech, Inc., San Francisco, California., Groves C; Cytometry/Dynamic Omics in R&D Antibody Discovery and Protein Engineering, Astra Zeneca, Gaithersburg, Maryland., Hall C; ISAC SRL Emerging Leader, Arlington, Virginia.; Cytometry Core Facility, Wellcome Sanger Institute, Hinxton, UK., Haque Y; Flow Cytometry Facility, Department of Immunobiology and Infectious Diseases, King's College London, London, UK., Hedrick MN; Clinical Flow Cytometry, Bristol-Myers Squibb, Princeton, New Jersey., Hogg K; Imaging and Cytometry Laboratory, Bioscience Technology Facility, Department of Biology, University of York, York, UK., Hsieh EWY; Department of Immunology and Microbiology, Department of Pediatrics, Division of Allergy and Immunology, School of Medicine, University of Colorado, Aurora, Colorado., Irish J; Cancer & Immunology Core and Mass Cytometry Center of Excellence, Vanderbilt University, Nashville, Tennessee., Lederer J; Department of Surgery (Immunology), Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts., Leipold M; Human Immune Monitoring Center (HIMC), Stanford University, Stanford, California., Lewis-Tuffin LJ; Microscopy and Flow Cytometry Shared Resource, Mayo Clinic, Jacksonville, Florida., Litwin V; Caprion Biosciences, Inc., Immunology, Montreal, Quebec, Canada., Lopez P; Cytometry and Cell Sorting Laboratory, New York University School of Medicine, New York, New York., Nasdala I; Sysmex Partec GmbH, Münster, Germany., Nedbal J; Physics Department, King's College London, London, UK.; ISAC Marylou Ingram Scholar, Arlington, Virginia., Ohlsson-Wilhelm BM; SciGro, Inc., North Central Office, Pittsburgh, Pennsylvania., Price KM; Hugh Green Cytometry Centre, Malaghan Institute of Medical Research, Wellington, New Zealand., Rahman AH; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York.; Dept. of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Rayanki R; Cytometry/Dynamic Omics in R&D Antibody Discovery and Protein Engineering, Astra Zeneca, Gaithersburg, Maryland., Rieger AM; ISAC SRL Emerging Leader, Arlington, Virginia.; University of Alberta, Flow Cytometry Facility, Faculty of Medicine and Dentistry, Alberta, Canada., Robinson JP; College of Veterinary Medicine and Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana., Shapiro H; One World Cytometry, Inc, Newton, Massachusetts., Sun YS; Clinical Flow Cytometry, Bristol-Myers Squibb, Princeton, New Jersey., Tang VA; University of Ottawa, Flow Cytometry and Virometry Core Facility, Ottawa, Canada.; Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada., Tesfa L; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York., Telford WG; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Center Institute, National Institutes of Health, Bethesda, Maryland., Walker R; Flow Cytometry Core Facility, Babraham Institute, Cambridge, UK., Welsh JA; ISAC Marylou Ingram Scholar, Arlington, Virginia.; Laboratory of Pathology, Translational Nanobiology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Wheeler P; Flow Cytometry, Luminex Corporation, Peterborough, UK., Tárnok A; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.; Department Therapy Validation, Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.
Publikováno v:
Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2019 Dec; Vol. 95 (12), pp. 1236-1274.